GREENWICH, Conn., Feb. 16, 2018 /PRNewswire/ -- Great Point Partners, LLC ("GPP") today submitted a letter to the Board of Directors of BioCryst Pharmaceuticals, Inc. ("BCRX") expressing its opposition to
Growth Capitalist (https://growthcapitalist.com/2018/02/great-point-partners-llc-opposes-the-biocryst-pharmaceutical-proposed-merger-with-idera-pharmaceuticals-inc/)
GREENWICH, Conn., Feb. 16, 2018 /PRNewswire/ -- Great Point Partners, LLC ("GPP") today submitted a letter to the Board of Directors of BioCryst Pharmaceuticals, Inc. ("BCRX") expressing its opposition to